Selgitasime välja peamised poliitilised tegurid, mis puudutavad ja mõjutavad tõrjutud noorte immigrantide liikumist haridusmaastikult tööturule (või töötuks jäämiseni), hinnates ka sellest tulenevaid tagajärgi nende sotsiaalsele kaasatusele või tõrjutusele ning kodanikuaktiivsusele.
Uurisime, millistes valdkondades suudavad info- ja kommunikatsioonitehnoloogiad järgmise kümne aasta jooksul enim Eesti majanduse ja ühiskonna arengusse panustada
Offering a platform for cross-regional learning and providing concrete regional development concepts for knowledge-based technology regions in Europe.
Exploring the role national minorities had played in the process of democratic transition in South, Central and Eastern Europe and to identifying best practices developed in the target countries to support minorities in realising their interests.
Eesti riikliku lõimumiskava 2008-2013 välja töötamine ning sellega seonduvate tegevuste korraldamine.
Development and implementation of strategic policy intelligence tools for better science and technology investment strategies in Europe’s regions.
Helping to make RTD policies directed to SMEs of EU Member States and acceding countries alike more effective and therefore to promote innovation in Europe resulting in higher growth rates of Europe’s future-oriented sectors of the economy.
Offering the the participating regions a framework in which they can develop and test methodologies and tools in transnational partnership project aiming at the assessment of the impact of their RTD policies and allowing benchmarking of these policies.
Supporting the national and sub-national research and innovation policy actors by providing a comprehensive methodology to translate the available results produced with the R&D activities into concrete policy making decisions by the means of innovative assessment tools.
Analüüsisime erinevate Euroopa regioonide võrdluses arenguseire kogemusi.
Carrying out activities to create and to work as a laboratory for innovative ideas to address the issues of access to innovation financing in the healthcare-dedicated Biotech sector, both from the investors side and from the biotech companies sides.
Developing specific guides and tools targeting innovative enterprises in the medical device sector, and validating such guides and tools through specific roundtable discussions between representatives from the financing community and the companies.